Literature DB >> 33436041

Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway.

Xuehui Wang1,2, Changle Ji1, Jiashu Hu1, Xiaochong Deng1, Wenfang Zheng1, Yunhe Yu1, Kaiyao Hua1, Xiqian Zhou1, Lin Fang3.   

Abstract

BACKGROUND: Circular RNAs (circRNAs), a novel class of endogenous RNAs, have shown to participate in the development of breast cancer (BC). Hsa_circ_0005273 is a circRNA generated from several exons of PTK2. However, the potential functional role of hsa_circ_0005273 in BC remains largely unknown. Here we aim to evaluate the role of hsa_circ_0005273 in BC.
METHODS: The expression level of hsa_circ_0005273 and miR-200a-3p were examined by RT-qPCR in BC tissues and cell lines. The effect of knocking down hsa_circ_0005273 in BC cell lines were evaluated by examinations of cell proliferation, migration and cell cycle. In addition, xenografts experiment in nude mice were performed to evaluate the effect of hsa_circ_0005273 in BC. RNA immunoprecipitation assay, RNA probe pull-down assay, luciferase reporter assay and fluorescence in situ hybridization were conducted to confirm the relationship between hsa_circ_0005273, miR-200a-3p and YAP1.
RESULTS: Hsa_circ_0005273 is over-expressed in BC tissues and cell lines, whereas miR-200a-3p expression is repressed. Depletion of hsa_circ_0005273 inhibited the progression of BC cells in vitro and in vivo, while overexpression of hsa_circ_0005273 exhibited the opposite effect. Importantly, hsa_circ_0005273 upregulated YAP1 expression and inactivated Hippo pathway via sponging miR-200a-3p to promote BC progression.
CONCLUSIONS: Hsa_circ_0005273 regulates the miR-200a-3p/YAP1 axis and inactivates Hippo signaling pathway to promote BC progression, which may become a potential biomarker and therapeutic target.

Entities:  

Keywords:  Breast cancer; Hippo signaling pathway; YAP1; hsa_circ_0005273; miR-200a-3p

Year:  2021        PMID: 33436041      PMCID: PMC7802350          DOI: 10.1186/s13046-021-01830-z

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  1 in total

1.  Screening and validation of lncRNAs and circRNAs as miRNA sponges.

Authors:  Giuseppe Militello; Tyler Weirick; David John; Claudia Döring; Stefanie Dimmeler; Shizuka Uchida
Journal:  Brief Bioinform       Date:  2017-09-01       Impact factor: 11.622

  1 in total
  13 in total

1.  S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway.

Authors:  Shaoqin Jiang; Yaru Zhu; Zhenlin Chen; Zhangcheng Huang; Bingqiao Liu; Yue Xu; Zhihao Li; Zequn Lin; Mengqiang Li
Journal:  Hum Cell       Date:  2021-04-23       Impact factor: 4.174

Review 2.  The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.

Authors:  Yirao Zhang; Yang Wang; Hao Ji; Jie Ding; Keming Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

Review 3.  Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

Authors:  Javeria Qadir; Feiya Li; Burton B Yang
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

Review 4.  Circular RNA and Its Roles in the Occurrence, Development, Diagnosis of Cancer.

Authors:  Yue Zhang; Xinyi Zhang; Yumeng Xu; Shikun Fang; Ying Ji; Ling Lu; Wenrong Xu; Hui Qian; Zhao Feng Liang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

5.  Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.

Authors:  Qiuli Wang; Dong Liang; Peng Shen; Yang Yu; Yuan Yan; Wei You
Journal:  Transl Oncol       Date:  2021-05-20       Impact factor: 4.243

6.  EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway.

Authors:  Xuehui Wang; Hongming Song; Lin Fang; Tianqi Wu
Journal:  Cell Death Discov       Date:  2022-03-02

7.  Differential expression profile of mRNAs, lncRNAs, and circRNAs reveals potential molecular mechanism in breast cancer.

Authors:  Yuan Li; Chiseng Lei; Yude Xie; Jie Zhang; Ningxia Wang; Weili He; Shaohua Qu
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 8.  Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.

Authors:  Ohanes Ashekyan; Samira Abdallah; Ayman Al Shoukari; Ghada Chamandi; Hayat Choubassy; Abdul Rahman S Itani; Nisreen Alwan; Rihab Nasr
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

9.  Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway.

Authors:  Chunxue Li; Rongrong Zhang; Yating Zhan; Jianjian Zheng
Journal:  Mediators Inflamm       Date:  2021-10-13       Impact factor: 4.711

10.  Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.

Authors:  QunXue Su; Hao Shen; Bei Gu; Ning Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.